Drug Trial Radar · NCT06482112
Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016)
Last checked: Nov 19, 2026Latest source record: Jun 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
124
Actual
Start
Jul 29, 2024
Primary completion
Jun 27, 2025
Study completion Jun 27, 2025
Sponsor
- Lead sponsor
- Merck Sharp & Dohme LLCMerck & Co. (MRK)
- Sponsor type
- Industry
- First posted
- Jul 1, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the effect of efinopegdutide administration once every 2 weeks (Q2W) versus once weekly (Q1W) on mean relative reduction from baseline in liver fat content (LFC) after 28 weeks, as well as the safety and tolerability of the different regimens of efinopegdutide.
Conditions
- Metabolic Dysfunction-Associated Steatotic Liver Disease
- Non-alcoholic Fatty Liver Disease
- Nonalcoholic Fatty Liver Disease
- Liver Disease
Interventions
EfinopegdutideDrug
SC injections in dose-escalation regimens potentially including doses of 2 mg, 4 mg, 7 mg, and 10 mg in all arms and 15 mg in the Efinopegdutide Q2W 15 mg arm
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Relative Reduction From Baseline in Liver Fat Content at Week 28Time frame: Baseline and Week 28
- Percentage of Participants Who Experienced an Adverse Event (AE)Time frame: Up to Week 32
- Percentage of Participants Who Discontinued Study Intervention Due to an AETime frame: Up to Week 28
Locations
39 sites in 2 countries. Site status is shown where the registry gives one.
The Institute for Liver Health II dba Arizona Clinical Trial-The Institute for Liver Health ( Site 0
Chandler, Arizona
The Institute for Liver Health II dba Arizona Liver Health - Peoria ( Site 0224)
Peoria, Arizona
Arizona Liver Health ( Site 0211)
Tucson, Arizona
Del Sol Research Management, LLC ( Site 0209)
Tucson, Arizona
Om Research LLC ( Site 0207)
Camarillo, California
Gastroenterology and Liver Institute ( Site 0263)
Escondido, California
Velocity Clinical Research, Gardena ( Site 0235)
Gardena, California
Velocity Clinical Research, Huntington Park ( Site 0210)
Huntington Park, California
California Liver Research Institute ( Site 0216)
Pasadena, California
Acclaim Clinical Research ( Site 0241)
San Diego, California
Velocity Clinical Research, Santa Ana ( Site 0250)
Santa Ana, California
Velocity Clinical Research, Panorama City ( Site 0228)
Van Nuys, California
Excel Medical Clinical Trials ( Site 0268)
Boca Raton, Florida
AGA Clinical Trials ( Site 0274)
Hialeah, Florida
Neoclinical Research ( Site 0275)
Hialeah, Florida
Homestead Associates in Research, Inc. ( Site 0243)
Homestead, Florida
Floridian Clinical Research, LLC ( Site 0208)
Miami Lakes, Florida
Southeast Clinical Research Center ( Site 0223)
Dalton, Georgia
Velocity Clinical Research Rockville ( Site 0245)
Rockville, Maryland
The Machuca Foundation ( Site 0218)
Las Vegas, Nevada
Excel Clinical Research, LLC ( Site 0200)
Las Vegas, Nevada
Basil Clinical ( Site 0246)
Inwood, New York
Lucas Research, Inc ( Site 0204)
Morehead City, North Carolina
Texas Clinical Research Institute ( Site 0230)
Arlington, Texas
Pinnacle Clinical Research ( Site 0203)
Austin, Texas
Velocity Clinical Research, Austin ( Site 0201)
Austin, Texas
Pinnacle Clinical Research-Corpus Christi ( Site 0267)
Corpus Christi, Texas
Zenos Clinical Research ( Site 0240)
Dallas, Texas
South Texas Research Institute ( Site 0226)
Edinburg, Texas
Houston Research Institute ( Site 0221)
Houston, Texas
American Research Corporation ( Site 0234)
San Antonio, Texas
Clinical Trials of Texas, LLC-Clinical Research ( Site 0252)
San Antonio, Texas
Pinnacle Clinical Research-Clinical Research Coordination ( Site 0229)
San Antonio, Texas
Impact Research Institute ( Site 0227)
Waco, Texas
Olympus Family Medicine/CCT Research ( Site 0266)
Holladay, Utah
South Ogden Family Medicine/ CCT Research ( Site 0255)
South Ogden, Utah
San Juan Bautista School of Medicine - Clinical Research Unit ( Site 0104)
Caguas, Puerto Rico
Klinical Investigations Group-Clinical Research ( Site 0100)
San Juan, Puerto Rico
Pan American Center for Oncology Trials - Ciudadela ( Site 0101)
San Juan, Puerto Rico
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.